Contact lens breakthrough lets humans see infrared light
29 May, 2025Newly created contact lenses enable infrared vision in both humans and mice by converting infrared light into visible light — which could transform medical imaging and visual assistance technologies.
TGA approves donanemab for treatment of early Alzheimer's
23 May, 2025The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in Australia, while Spanish researchers have presented a new family of candidate compounds for the treatment of Alzheimer's and pain.
Diabetes drug reduces knee arthritis pain in overweight patients
16 May, 2025A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements.
Anti-inflammatory drug may help treat alcohol use disorder
09 May, 2025A drug that is already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity — two issues that commonly co-occur with alcohol use disorder.
Preventing neural graft rejection in Parkinson's patients
01 May, 2025Researchers have engineered a way to fool the immune system into accepting neural grafts as part of the body, rather than attacking them as foreign objects.
Breakthrough drug prevents long COVID symptoms in mice
24 April, 2025Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction — key symptoms of long COVID.
Sleep apnoea patients who use CPAP live longer: study
11 April, 2025CPAP therapy has been found to significantly reduce the risk of death for people with obstructive sleep apnoea (OSA), according to a new meta-analysis.
Human milk harnessed to administer medicine to infants
19 March, 2025The Monash Milk Team are trailblazers in understanding how milk and milk-like systems can be harnessed to enhance oral drug delivery.
Tumour-invading protein delivers therapy straight to the brain
14 March, 2025A protein called HER3, which is present on the blood–brain barrier, helps the tumour-invading protein cross from the bloodstream to the brain.
Success for Australia's first Total Artificial Heart implant
12 March, 2025The recipient of the implant was discharged from hospital in February and received a donor transplant in March — 105 days after the procedure was performed.
Surface coating could prevent blood clots in medical implants
11 March, 2025Zwitterions — a common macromolecule found in human cells — are being used to create materials that could stop blood clots from forming in medical devices like heart valves.
mRNA successfully delivered through blood–brain barrier
07 March, 2025Getting mRNA into the brain could allow scientists to instruct brain cells to produce therapeutic proteins that can help treat or prevent disease.
Targeted therapy for childhood brain cancer shows promise
21 February, 2025A potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumour cells in preclinical models.
TGA approves first treatment for geographic atrophy
07 February, 2025Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to slow down the progression of geographic atrophy.
Specially designed peptides can treat complex diseases
06 February, 2025Two separate research teams have found ways to create short chains of amino acids, termed peptides, for the purpose of treating a variety of diseases — including cancer.
